Condition: Primary Hyperaldosteronism Due to Adrenal Adenoma · Sponsor: Göteborg University
This is a prospective randomized controlled trial where quality of life and the effectiveness of treatment will be evaluated in 80 patients with confirmed unilateral primary aldosteronism ,randomly assigned to be either treated surgically with unilateral adrenalectomy or to receive medical treatment with eplerenone.
This description comes directly from the study's public registry record.
Oskar Ragnarsson, MD · 00460313421000 · oskar.ragnarsson@medic.gu.se
Always discuss trial participation with your own doctor first.
| University of Gothenburg | Gothenburg, Sweden | Recruiting |
| Karolinska University Hospital, Stockholm, Sweden. | Stockholm, Sweden | Not Yet Recruiting |
| Umeå University, Umeå, Sweden. | Umeå, Sweden | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05797558